GAMMA Investing’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

GAMMA Investing’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-143	Closed	-$2.25K	–	3533
2024 Q1	$2.25K	Buy	143 +75	+110%	+$1.15K	﹤0.01%	2717
2023 Q4	$974	Buy	+68	New	+$867	﹤0.01%	2795

Other funds holding DCPH

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

GAMMA Investing's DCPH Position: Q2 2024 in Review

GAMMA Investing sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 143 shares — an estimated $2.25K sold.

GAMMA Investing first reported a position in DCPH in Q4 2023 and held it in 2 quarters. The position peaked at $2.25K in Q1 2024. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.

GAMMA Investing reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
GAMMA Investing sold 143 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $2.25K.
GAMMA Investing first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2023 and held it in 2 quarters.
GAMMA Investing's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $2.25K in Q1 2024.
1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on GAMMA Investing's 13F filing for Q2 2024, filed 2 Jul 2024.